OakChart

Boston Scientific Corp

BSXHealthcare·Medical Devices·USA·Large·NYSE·Nov 11 • 3:10 PM ET

45.38+0.68 (1.52%)
2026-11-11 21:10 CET
Market cap
64,791.31 USD m
Revenue, TTM
21,069.00 USD m
Net income, TTM
3,502.00 USD m
Free cash flow, TTM
3,331.00 USD m
EPS diluted, TTM
2.36
P/E
19.21
Compare

Price

BSX against its 20, 50 and 200-day averages
2050200beatmiss
40.0060.0080.0034.9M69.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BSXclose 45.3820-day 44.4150-day 44.15200-day 54.6345.3852w low

57.0% under the 52-week high of 105.65 on 13 Nov 2025. 52-week low 39.57 on 28 Oct 2026. Last 15 sessions, 18.7% high to low

Volume 0.60× normal · the line is the 50-bar volume average

Profile

BSX
52-week range, 9% of the way up
39.57105.65

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

IndexS&P 500, RUI
Employees59000
IPOMay 19, 1992
Beta0.57
ATR, 14d1.77
Rel volume0.60
Short float2.44%
Insider own0.65%
Inst own94.81%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap65.78B
Enterprise Value77.31B
Income3.50B
Sales21.07B
Book/sh17.68
Cash/sh0.46
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees59000
IPOMay 19, 1992

Ratios

P/E19.21
Forward P/E14.54
PEG4.67
P/S3.12
P/B2.57
P/C98.62
P/FCF19.75
EV/EBITDA12.99
EV/Sales3.67
Quick Ratio0.81
Current Ratio1.36
Debt/Eq0.47
LT Debt/Eq0.43
Option/ShortYes / Yes

Earnings

EPS (ttm)2.36
EPS next Y3.12
EPS next Q0.78
EPS this Y3.36%
EPS next Y-1.29%
EPS next 5Y3.11%
EPS past 3/5Y63.23% -
Sales past 3/5Y16.54% 15.16%
EPS Y/Y TTM25.77%
Sales Y/Y TTM8.88%
EPS Q/Q-20.60%
Sales Q/Q1.44%
EarningsOct 28 BMO
EPS/Sales Surpr.0.43% 0.99%

Ownership

Insider Own0.65%
Insider Trans2.24%
Inst Own94.81%
Inst Trans0.42%
ROA7.94%
ROE14.29%
ROIC9.58%
Gross Margin65.59%
Oper. Margin21.44%
Profit Margin16.62%
SMA202.18%
SMA502.79%
SMA200-16.94%
Trades-

Technical

Shs Outstand1.45B
Shs Float1.44B
Short Float2.44%
Short Ratio1.78
Short Interest35.11M
52W High105.65 -57.05%
52W Low39.57 14.68%
Volatility4.01% 3.60%
ATR (14)1.77
RSI (14)54.35
Beta0.57
Rel Volume0.60
Avg Volume19.77M
Volume10,387,970

Performance

Perf Week-0.96%
Perf Month4.78%
Perf Quarter-12.21%
Perf Half Y-14.47%
Perf YTD-52.41%
Perf Year-55.73%
Perf 3Y-11.99%
Perf 5Y8.15%
Perf 10Y111.07%
Recom1.78
Target Price49.93
Prev Close44.70
Price45.38
Change %1.52%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 30, 2026DowngradeTTD CowenBuy → Hold$46+1.4%
Oct 29, 2026DowngradeOOppenheimerOutperform → Perform
Oct 28, 2026DowngradeJJP MorganOverweight → Neutral$46+1.4%
Oct 07, 2026InitiatedBBarclaysEqual Weight$48+5.8%
Sep 17, 2026DowngradeCCitigroupBuy → Neutral$50+10.2%
Jul 31, 2026DowngradeAArgusBuy → Hold
May 29, 2026DowngradeWWolfe ResearchOutperform → Peer Perform
May 28, 2026DowngradeWWells FargoOverweight → Equal Weight$55+21.2%
Mar 30, 2026DowngradeRRaymond JamesStrong Buy → Outperform$88+93.9%
Oct 03, 2025DowngradeEErste GroupBuy → Hold

Peers

Mkt cap
TickerCompanyMkt cap
MDTMedtronic Plc129.77B
ABTAbbott Laboratories190.43B
EWEdwards Lifesciences Corp60.81B
SYKStryker Corp121.00B
PENPenumbra Inc12.68B
BDXBecton Dickinson & Co58.14B
JNJJohnson & Johnson674.41B
ATRCAtricure Inc2.87B
ISRGIntuitive Surgical Inc155.48B
TFXTeleflex Incorporated6.19B

Insider trading

latest 14 of 54
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
O'Sullivan MiriamSVP, Chief HR OfficerNov 01 '26Option Exercise0.003,871021,437Nov 03 06:14 PM
O'Connor Padraig AndrewEVP, Global OperationsSep 02 '26Option Exercise0.001,17108,459Sep 03 04:34 PM
Morano Susan EDirectorAug 25 '26Buy49.222,040100,40813,784Aug 26 06:46 PM
Habiger David CDirectorAug 05 '26Buy47.592,10099,93717,160Aug 07 04:16 PM
Habiger David CDirectorAug 03 '26Buy48.071,04250,08414,920Aug 05 04:15 PM
Habiger David CDirectorAug 04 '26Buy48.591406,80215,060Aug 05 04:15 PM
Mahoney Michael FChairman, President & CEOAug 03 '26Buy48.33186,2409,001,4081,590,024Aug 05 04:15 PM
LUDWIG EDWARD JDirectorJul 31 '26Buy45.485,000227,40030,359Aug 03 04:29 PM
Monson JonathanEVP and CFOJul 01 '26Option Exercise0.002,087040,073Jul 02 04:07 PM
Pegus CherylDirectorMay 20 '26Buy56.491,77099,9871,770May 21 05:21 PM
LUDWIG EDWARD JDirectorMay 20 '26Buy56.683,580202,91425,359May 21 05:21 PM
Habiger David CDirectorMay 20 '26Buy55.922,250125,81913,878May 21 05:20 PM
Habiger David CDirectorMay 19 '26Buy56.952,200125,27911,628May 21 05:20 PM
O'Connor Padraig AndrewEVP, Global OperationsMay 02 '26Option Exercise0.001,80207,896May 04 05:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VHTVanguard Health Care ETFAUM: 21.51B
VOEVanguard Morningstar Mid-Cap Value ETFAUM: 24.66B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-280.7300.7270.4005,1385,08825
2026Q22026-07-290.8600.8360.6155,4425,37524
2026Q12026-04-220.8000.7880.8975,2035,17327
2025Q42026-02-040.8000.7810.4495,2865,28028
2025Q32025-10-220.7500.7140.5055,0654,96928
2025Q22025-07-230.7500.7260.5345,0614,89327
2025Q12025-04-230.7500.6730.4514,6634,57226
2024Q42025-02-050.7000.6570.3804,5614,42028
2024Q32024-10-230.6300.5880.3154,2094,04129
2024Q22024-07-240.6200.5830.2184,1204,02929
2024Q12024-04-240.5600.5140.3343,8563,68428
2023Q42024-01-310.5500.5130.3413,7253,59325
2023Q32023-10-260.5000.4770.3423,5273,47727
2023Q22023-07-270.5300.4900.1793,5993,50228
2023Q12023-04-260.4700.4330.2083,3893,15625
2022Q42023-02-010.4500.4720.0873,2423,24324

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.5801.5683.33210,73510,740
2020FY0.9601.045-0.0819,91310,029
2021FY1.6301.6130.68711,88811,873
2022FY1.7101.7350.44612,68212,684
2023FY2.0502.0111.07314,24014,116
2024FY2.5102.4651.24716,74716,609
2025FY3.0603.0361.94020,07420,071
2026FY-3.163--20,968
2027FY-3.122--20,792
2028FY-3.355--21,861
2029FY-3.650--23,199
2030FY-4.008--25,569

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-03250255,1805,1395,246
2026Q4S2026-11-02250245,1905,1395,471
2026Q4S2026-10-29250245,1905,1395,471
2026Q4S2026-10-28250225,2095,1395,471
2026Q4S2026-10-27250105,3685,1415,822
2026Q4S2026-10-2325165,4215,2045,822
2026Q4S2026-10-2225165,4215,2045,822
2026Q4S2026-10-2125165,4215,2045,822
2026Q4S2026-10-1325165,4215,2045,822
2026Q4S2026-10-1225155,4245,2045,822
2026Q4S2026-10-11251205,4245,2045,822
2026Q4S2026-10-10251225,4245,2045,822
2026Q4S2026-10-09251235,4245,2045,822
2026Q4S2026-10-08251235,4245,2045,822

Estimate history

EPS, annual0.0751.1923.332-0.0810.6870.4461.0731.2471.9392.3621
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3150.380.4510.5340.5050.4490.8970.6150.401
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual90489823107359913118881268214240167472007421069
Period201720182019202020212022202320242025TTM
Sales, quarterly420945614663506150655286520354425138
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1373.4971384.5821394.9231416.6221425.521433.3441465.711474.55614831449.466
Period201720182019202020212022202320242025MRQ
Shares, quarterly1473.4421474.5561479.1981480.3431482.28314831486.2941446.7061449.466
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue21,069.0020,074.0016,747.0014,240.0012,682.0011,888.009,913.0010,735.009,823.00
Cost of Goods Sold Incl. D&A7,249.007,018.006,480.005,409.004,968.004,427.004,337.003,856.003,346.00
Gross Profit13,820.0013,056.0010,267.008,831.007,714.007,461.005,576.006,879.006,477.00
Selling, General and Administrative Excl. Other9,260.008,939.007,599.006,604.005,843.005,490.004,930.005,102.004,670.00
Research and Development2,159.002,052.001,615.001,414.001,323.001,204.001,143.001,174.001,113.00
Other Operating Expense42.0046.0033.0046.0047.0049.0045.0065.0070.00
Operating Income4,518.004,071.002,635.002,181.001,824.001,922.00601.001,712.001,737.00
Interest Expense339.00325.00387.00272.00464.00349.00468.00513.00269.00
Unusual Expense396.00533.0032.0071.00417.00871.00690.00610.00171.00
Net Income Before Taxes3,656.003,385.002,282.001,985.001,141.001,076.00-79.00687.001,422.00
Income Taxes162.00493.00436.00393.00443.0036.002.00-4,013.00-249.00
Consolidated Net Income3,494.002,892.001,846.001,592.00698.001,040.00-82.004,700.001,671.00
Net Income From Continuing Operations3,502.002,898.001,854.001,593.00698.001,040.00-82.004,700.001,671.00
Net Income3,502.002,898.001,853.001,570.00642.00985.00-115.004,700.001,671.00
EPS (Recurring)2.602.191.261.110.651.110.263.631.28
EPS (Basic, Before Extraordinaries)2.381.961.261.080.450.69-0.083.381.21
EPS (Diluted)2.361.941.251.070.450.69-0.083.331.19
EBITDA5,951.005,439.003,904.003,377.002,960.003,015.001,723.002,722.002,631.00
Non-Operating Income (Expense)-131.00171.0066.00147.00198.00374.00478.0098.00125.00
Other After Tax Adjustments0.000.000.000.000.000.00-1.000.000.00
Stock Option Compensation Expense-257.00227.00184.07173.80141.62124.10133.00119.00
Price To Earnings Ratio18.9218.9273.8870.81111.4761.89-13.5929.70
Price To Sales Ratio3.017.107.935.945.255.125.145.945.04
Gross Margin65.5965.0461.3162.0260.8362.7656.2564.0865.94
Operating Margin21.4420.2815.7315.3214.3816.176.0615.9517.68
Net Margin16.6214.4411.0611.035.068.29-1.1643.7817.01
Shares Outstanding1,449.471,483.001,474.561,465.711,433.341,425.521,416.621,394.921,384.58
Market Capitalization64,791.3164,791.31131,642.5084,690.4966,272.9860,533.5851,477.5263,028.5448,903.49

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue5,138.005,442.005,203.005,286.005,065.005,061.004,663.004,561.00
Cost of Goods Sold Incl. D&A1,942.001,823.001,819.001,665.001,757.001,883.001,713.001,890.00
Gross Profit3,196.003,619.003,384.003,621.003,308.003,178.002,950.002,671.00
Selling, General and Administrative Excl. Other2,203.002,357.002,297.002,403.002,255.002,242.002,040.002,072.00
Research and Development520.00554.00516.00569.00514.00526.00443.00460.00
Other Operating Expense12.0012.0012.006.0012.0014.0014.0010.00
Operating Income981.001,250.001,075.001,212.001,041.00922.00896.00589.00
Interest Expense108.00104.0093.0034.0096.0099.0087.00139.00
Unusual Expense164.0063.00-37.00206.0013.00256.0057.00-233.00
Net Income Before Taxes733.001,060.001,163.00700.00938.00941.00805.00585.00
Income Taxes153.00155.00-176.0030.00183.00146.00133.0023.00
Consolidated Net Income580.00905.001,339.00670.00755.00795.00672.00562.00
Net Income From Continuing Operations582.00907.001,341.00672.00755.00797.00674.00566.00
Net Income582.00907.001,341.00672.00755.00797.00674.00566.00
EPS (Recurring)0.480.640.880.550.510.650.480.27
EPS (Basic, Before Extraordinaries)0.400.620.900.450.510.540.460.38
EPS (Diluted)0.400.610.900.450.500.530.450.38
EBITDA1,343.001,605.001,426.001,577.001,383.001,258.001,221.00937.00
Non-Operating Income (Expense)23.00-24.00141.00-271.005.00375.0053.00-99.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-67.1562.4156.0962.4159.2558.4654.51
Price To Earnings Ratio18.9217.9032.3651.0058.1178.7080.8773.88
Price To Sales Ratio3.013.004.557.107.558.678.587.95
Gross Margin62.2066.5065.0468.5065.3162.7963.2658.56
Operating Margin19.0922.9720.6622.9320.5518.2219.2212.91
Net Margin11.3316.6725.7712.7114.9115.7514.4512.41
Shares Outstanding1,449.471,446.711,486.291,483.001,482.281,480.341,479.201,474.56
Market Capitalization64,791.3163,437.8493,114.10141,350.65144,663.25158,907.72149,208.58131,642.50

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2,045.00525.00995.001,077.002,113.001,942.00563.00801.00991.00
Short Term Receivables2,926.002,558.002,228.001,970.001,778.001,531.001,933.001,608.001,548.00
Inventories2,944.002,810.002,484.001,867.001,610.001,351.001,579.001,166.001,078.00
Other Current Assets879.001,027.00807.00846.00816.001,870.00624.00427.00205.00
Total Current Assets8,794.006,920.006,514.005,760.006,317.006,694.004,699.004,002.003,822.00
Net Property, Plant & Equipment4,501.003,743.003,298.002,832.002,687.002,542.002,415.001,782.001,697.00
Total Investments and Advances842.00714.00598.00603.00635.001,077.00694.00397.00305.00
Long-Term Note Receivable---1.000.002.0023.0026.0047.00
Intangible Assets25,302.0023,773.0020,390.0018,822.0018,109.0015,868.0018,062.0014,283.0012,835.00
Deferred Tax Assets3,675.003,655.003,841.003,942.004,142.004,210.004,196.0087.0088.00
Other Assets559.00590.00495.00509.00339.00384.00476.00422.00248.00
Total Assets43,673.0039,395.0035,136.0032,469.0032,229.0030,777.0030,565.0020,999.0019,042.00
Short Term Debt Incl. Current Port. of LT Debt389.001,859.00531.0020.00332.0083.001,483.002,253.001,801.00
Accounts Payable1,144.00960.00942.00862.00794.00513.00542.00349.00530.00
Income Tax Payable-268.00220.00232.00209.00158.00265.00--
Other Current Liabilities3,906.003,312.003,240.002,689.002,939.002,927.002,576.002,658.003,323.00
Total Current Liabilities5,439.006,399.004,933.003,803.004,274.003,681.004,866.005,260.005,654.00
Long Term Debt11,583.009,369.008,961.009,262.009,193.009,531.008,868.004,803.003,815.00
Provision for Risks Charges0.00149.00172.00212.00284.0064.00227.00426.00569.00
Deferred Tax Liabilities220.00155.00134.00144.00310.00330.00595.00328.00191.00
Other Liabilities1,959.001,320.001,406.001,475.001,546.001,844.002,132.001,456.001,801.00
Total Liabilities19,201.0017,392.0015,606.0014,896.0015,607.0015,450.0016,688.0012,273.0012,030.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity24,233.0021,770.0019,282.0017,573.0016,622.0015,327.0013,877.008,726.007,012.00
Total Shareholders Equity24,233.0021,770.0019,282.0017,573.0016,622.0015,327.0013,877.008,726.007,012.00
Accumulated Minority Interest239.00233.00248.000.000.000.000.000.000.00
Total Equity24,472.0022,003.0019,530.0017,573.0016,622.0015,327.0013,877.008,726.007,012.00
Total Liabilities & Stockholders Equity43,673.0039,395.0035,136.0032,469.0032,229.0030,777.0030,565.0020,999.0019,042.00
Book Value Per Share16.3414.7613.1612.2611.6610.829.956.305.11
Tangible Book Value Per Share-0.72-1.36-0.76-0.87-1.04-0.38-3.00-4.01-4.24
Full-Time Employees59,00053,00048,00045,00041,00038,00036,00032,00029,000
Price to Book Ratio2.536.364.483.763.643.324.555.614.48
Return on Assets6.984.984.712.163.30-0.2718.238.350.56
Return on Equity12.609.038.644.086.51-0.5641.5921.241.51
Return on Invested Capital8.095.955.642.604.03-0.3320.6612.350.96
Quick Ratio1.080.640.821.021.101.450.640.540.49
Current Ratio1.621.081.321.511.481.820.970.760.68

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income3,493.002,892.001,846.001,592.00698.001,041.00-82.004,700.001,671.00
Depreciation1,432.001,368.001,269.001,196.001,136.001,093.001,123.001,011.00894.00
Other Funds (Non Cash)361.00522.00852.00485.00697.0088.00425.00-3,593.00-95.00
Funds from Operations5,018.004,780.003,897.003,273.002,531.002,222.001,466.002,118.002,470.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-784.00-246.00-462.00-770.00-1,005.00-351.0042.00-282.00-2,160.00
Cash from Operating Activities4,234.004,534.003,435.002,503.001,526.001,871.001,508.001,836.00310.00
Capital Expenditures-903.00-876.00-790.00-711.00-588.00-554.00-376.00-461.00-316.00
Net Assets From Acquisitions-1,019.00-1,593.00-4,640.00-1,811.00-1,542.00-2,258.00-3.00-4,382.00-1,448.00
Sale of Fixed Assets and Businesses0.000.003.004.0017.00840.0027.0097.0015.00
Purchase or Sale of Investments-1,619.00-254.00-260.00-59.0046.00361.00-146.00-149.00-172.00
Purchase of Investments-1,875.00-254.00-280.00-89.00-24.000.00-146.00-149.00-172.00
Sale Or Maturity of Investments256.000.0020.0030.0070.00361.000.000.000.00
Other Uses0.000.000.000.000.000.000.00-199.000.00
Other Sources46.0084.000.003.0056.0014.0087.0053.000.00
Cash from Investing Activities-3,496.00-2,640.00-5,687.00-2,574.00-2,011.00-1,597.00-411.00-5,041.00-1,921.00
Cash Dividends Paid0.000.000.00-28.00-55.00-55.00-28.000.000.00
Change in Capital Stock-1,799.00282.00230.00182.00136.00110.001,526.00123.00101.00
Repurchase of Common Pref Stock-2,000.000.000.000.000.000.00-535.000.000.00
Sale of Common Pref Stock201.00282.00230.00182.00136.00110.002,061.00123.00101.00
Proceedsfrom Stock Options201.00282.00230.00182.00136.00110.002,061.00123.00101.00
Issuance or Reduction of Debt, Net326.00-491.001,827.00-4.00-165.000.00-999.002,794.001,405.00
Change in Long Term Debt-209.001,300.002,120.000.0086.000.00420.003,669.00385.00
Issuance of Long Term Debt0.001,558.002,145.000.003,270.000.003,599.007,229.001,556.00
Reduction of Long Term Debt-209.00-258.00-25.000.00-3,184.000.00-3,179.00-3,560.00-1,171.00
Net Financing Active Other Cash Flow50.00-186.00-243.00-145.00-464.00-150.00-206.0056.00-74.00
Other Financing Activities Uses35.00-193.00-243.00-145.00-464.00-150.00-206.00-200.00-74.00
Cash from Financing Activities-1,423.00-395.001,814.005.00-548.00-95.00293.002,973.001,432.00
Exchange Rate Effect6.0042.00-11.00-4.00-9.00-6.00-2.0010.00-8.00
Net Change in Cash-679.001,541.00-449.00-70.00-1,042.00173.001,388.00-222.00-187.00
Free Cash Flow3,331.003,658.002,645.001,792.00938.001,317.001,132.001,375.00-6.00
Preferred Dividends (Cash Flow)-0.000.00-28.00-55.00-55.00-28.000.000.00
Price to Free Cash Flow19.0338.9650.1847.9675.4448.2646.1346.39-
Deferred Taxes & Investment Tax Credit--2.00-70.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments667.00648.001,524.002,045.001,373.00643.00
Short Term Receivables3,113.003,049.003,027.002,926.002,828.002,815.00
Inventories3,317.003,235.003,117.002,944.002,921.002,861.00
Other Current Assets1,068.001,041.001,016.00879.00912.00802.00
Total Current Assets8,164.007,972.008,684.008,794.008,035.007,121.00
Net Property, Plant & Equipment4,720.004,679.004,610.004,501.004,290.003,953.00
Total Investments and Advances2,520.002,488.00935.00842.00792.00745.00
Intangible Assets25,596.0025,558.0025,596.0025,302.0025,376.0025,336.00
Deferred Tax Assets3,840.003,909.003,953.003,675.003,669.003,778.00
Other Assets621.00609.00573.00559.00547.00627.00
Total Assets45,461.0045,216.0044,351.0043,673.0042,707.0041,559.00
Short Term Debt Incl. Current Port. of LT Debt1,044.001,709.0041.00389.00483.00480.00
Accounts Payable1,250.001,231.001,141.001,144.001,002.00962.00
Income Tax Payable----174.00173.00
Other Current Liabilities3,688.003,488.003,389.003,906.003,669.003,575.00
Total Current Liabilities5,982.006,428.004,571.005,439.005,328.005,190.00
Long Term Debt10,909.0010,915.0010,988.0011,583.0011,562.0011,547.00
Provision for Risks Charges0.000.000.000.00154.00169.00
Deferred Tax Liabilities264.00221.00219.00220.00242.00226.00
Other Liabilities2,434.002,480.002,469.001,959.001,791.001,774.00
Total Liabilities19,589.0020,044.0018,247.0019,201.0019,077.0018,906.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity25,630.0024,930.0025,864.0024,233.0023,394.0022,418.00
Total Shareholders Equity25,630.0024,930.0025,864.0024,233.0023,394.0022,418.00
Accumulated Minority Interest243.00242.00240.00239.00236.00235.00
Total Equity25,873.0025,172.0026,104.0024,472.0023,630.0022,653.00
Total Liabilities & Stockholders Equity45,462.0045,216.0044,351.0043,673.0042,707.0041,559.00
Book Value Per Share17.6817.2317.4016.3415.7815.14
Tangible Book Value Per Share0.02-0.430.18-0.72-1.34-1.97
Full-Time Employees---59,000--
Price to Book Ratio2.532.453.846.046.457.15
Return on Assets7.948.478.446.986.916.37
Return on Equity14.2915.5214.8312.6012.6611.71
Return on Invested Capital1.592.533.641.882.162.35
Quick Ratio0.810.741.221.080.960.82
Current Ratio1.361.241.901.621.511.37

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income580.00904.001,339.00670.00755.00795.00
Depreciation361.00355.00351.00365.00342.00336.00
Other Funds (Non Cash)117.00124.00-76.00196.00133.0012.00
Funds from Operations1,146.001,400.001,263.001,209.001,299.001,053.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-98.0074.00-915.00155.0044.00233.00
Cash from Operating Activities1,048.001,474.00348.001,364.001,343.001,286.00
Capital Expenditures-180.00-195.00-177.00-351.00-181.00-157.00
Net Assets From Acquisitions-212.00-195.00-523.00-89.00-256.00-1,009.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-44.00-1,562.0061.00-74.00-70.00-33.00
Purchase of Investments-71.00-1,730.000.00-74.00-70.00-33.00
Sale Or Maturity of Investments27.00168.0061.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.00-5.0048.003.005.0073.00
Cash from Investing Activities-437.00-1,956.00-591.00-512.00-502.00-1,126.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock95.00-1,995.0081.0020.00115.0032.00
Repurchase of Common Pref Stock0.00-2,000.000.000.000.000.00
Sale of Common Pref Stock95.005.0081.0020.00115.0032.00
Proceedsfrom Stock Options95.005.0081.0020.00115.0032.00
Issuance or Reduction of Debt, Net-672.001,662.00-259.00-405.00-19.00-314.00
Change in Long Term Debt0.000.000.00-209.00-7.00-6.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.00-209.00-7.00-6.00
Net Financing Active Other Cash Flow7.00-76.00-82.00201.00-201.00-58.00
Other Financing Activities Uses7.00-81.00-85.00194.00-201.00-58.00
Cash from Financing Activities-569.00-410.00-260.00-184.00-104.00-340.00
Exchange Rate Effect2.001.000.003.00-2.002.00
Net Change in Cash44.00-891.00-503.00671.00735.00-178.00
Free Cash Flow868.001,279.00171.001,013.001,162.001,129.00
Price to Free Cash Flow19.0317.3627.0038.9938.1846.03

Revenue breakdown

Cardiac Rhythm Management2024: 2.28B 2025: 2.33B
Electrophysiology (EP)2024: 1.90B 2025: 3.33B
Global Endoscopy (Endo) Reporting Unit2024: 2.69B 2025: 2.92B
Global Neuromodulation (NM) Reporting Unit2024: 1.11B 2025: 1.20B
Global Urology and Pelvic Health Reporting Unit2024: 2.20B 2025: 2.71B
Interventional Cardiology & Vascular Therapies2024: 4.20B 2025: 4.64B
Interventional Oncology & Embolization2024: 856.00M 2025: 996.00M
Watchman2024: 1.52B 2025: 1.96B
United States2024: 16.75B 2025: 20.07B
Cardiovascular2024: 10.76B 2025: 13.25B
Consolidation, Policy2024: -1.00M
MedSurg2024: 5.99B 2025: 6.82B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.44%35.1M1440.0M19.58M
2026-10-152.83%40.7M1439.8M19.75M
2026-09-302.88%41.4M1439.8M19.98M
2026-09-153.23%46.5M1439.8M20.17M
2026-08-313.35%48.2M1439.8M20.31M
2026-08-141.92%27.6M1439.8M20.84M
2026-07-311.54%22.3M1441.9M20.90M
2026-07-151.91%28.3M1478.9M20.73M
2026-06-301.89%27.9M1478.9M20.47M
2026-06-152.01%29.8M1477.5M19.12M
2026-05-293.89%57.5M1478.9M17.87M
2026-05-152.13%31.4M1478.4M16.15M
2026-04-301.94%28.6M1478.7M17.79M
2026-04-151.73%25.6M1480.7M16.62M
2026-03-311.59%23.5M1480.7M15.98M
2026-03-131.72%25.4M1478.5M14.45M
2026-02-271.78%26.3M1478.5M13.79M
2026-02-131.80%26.6M1478.3M13.38M
2026-01-301.91%28.3M1477.4M10.07M
2026-01-151.59%23.4M1477.3M9.14M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call30.0015.1015.8015.494.1653.001.000.985-0.0920.001
call32.0013.2014.1013.134.0614.001.000.983-0.0900.001
call33.0012.2013.1012.203.7875.002.000.982-0.0890.001
call34.0011.1012.0011.243.3407.003.000.980-0.0870.002
call35.0010.1011.0010.483.08714.003.000.979-0.0860.002
call35.509.6010.209.922.5694.003.000.978-0.0850.002
call36.009.209.809.492.4683.005.000.977-0.0840.002
call36.508.709.208.992.34213.003.000.975-0.0830.002
call37.008.108.708.512.23060.003.000.974-0.0820.002
call37.507.708.308.072.1325.002.000.973-0.0810.002
call38.007.107.806.402.02114.000.000.972-0.0800.002
call38.506.707.207.071.89613.002.000.969-0.0790.002
call39.006.106.905.361.9606.000.000.968-0.0780.002
call39.505.606.305.891.6766.002.000.945-0.1260.004
call40.004.806.004.431.97223.000.000.940-0.1230.004
call40.504.505.504.851.80443.001.000.936-0.1200.004
call41.003.905.104.131.8315.001.000.928-0.1220.004
call41.503.404.602.561.6992800.000.912-0.1350.005
call42.003.004.103.211.5173761.000.897-0.1420.006
call42.501.853.602.081.43188.000.000.870-0.1570.007
call43.002.102.802.460.9981351.000.846-0.1600.008
call43.501.902.352.050.9212421.000.814-0.1620.009
call44.001.401.801.600.74133037.000.770-0.1630.010
call44.501.151.301.400.6205905.000.694-0.1700.011
call45.000.800.950.830.5711,32032.000.598-0.1780.013
call45.500.500.650.570.5411,71010.000.480-0.1750.013
call46.000.300.400.310.50546882.000.357-0.1580.012
call46.500.150.250.230.50426911.000.247-0.1330.010
call47.000.100.150.120.50538243.000.209-0.1470.009
call47.500.050.100.060.53058.0018.000.196-0.1730.009
call48.000.000.150.060.61453513.000.180-0.1890.009
call48.500.000.200.320.6951370.000.139-0.1600.007
call49.000.000.050.060.6411475.000.107-0.1290.006
call49.500.000.250.010.71154.002.000.078-0.1030.005
call50.000.000.200.150.7881032.000.048-0.0680.003
call51.000.000.200.070.90264.002.000.043-0.0710.003
call52.000.000.250.101.04833.005.000.038-0.0750.003
call53.000.000.400.041.1434.002.000.035-0.0760.003
call54.000.000.400.231.25773.002.000.032-0.0780.002
call55.000.000.400.181.36422.002.000.030-0.0800.002
call56.000.000.150.091.4702.002.000.028-0.0820.002
call60.000.000.050.031.7882.002.000.023-0.0810.002
call65.000.000.400.002.3140.000.000.019-0.0940.002
put30.000.000.400.102.7200.000.00-0.014-0.0830.001
put32.000.000.400.112.3515.000.00-0.016-0.0810.001
put33.000.000.400.292.1763.000.00-0.018-0.0800.001
put34.000.000.400.202.00212.000.00-0.019-0.0790.002
put35.000.000.400.081.8221400.00-0.021-0.0790.002
put35.500.000.400.101.7383.000.00-0.022-0.0790.002
put36.000.000.400.101.6551560.00-0.023-0.0770.002
put36.500.000.400.131.56912.000.00-0.024-0.0760.002
put37.000.000.400.081.49127.000.00-0.026-0.0770.002
put37.500.000.400.051.40011.000.00-0.027-0.0750.002
put38.000.000.400.101.35186.000.00-0.028-0.0760.002
put38.500.000.050.070.95224.000.00-0.033-0.0490.003
put39.000.000.050.100.88392.000.00-0.035-0.0480.003
put39.500.000.200.051.26713.000.00-0.055-0.1220.004
put40.000.000.150.091.1762520.00-0.059-0.1190.004
put40.500.000.100.081.0706230.00-0.064-0.1160.004
put41.000.000.300.120.9761240.00-0.072-0.1180.004
put41.500.000.100.050.88816849.00-0.088-0.1300.005
put42.000.000.100.100.7961,00229.00-0.107-0.1420.006
put42.500.000.100.050.70313078.00-0.130-0.1520.007
put43.000.000.200.100.68732925.00-0.154-0.1560.008
put43.500.050.150.100.58367.0020.00-0.186-0.1570.009
put44.000.100.200.100.53240412.00-0.230-0.1580.010
put44.500.200.300.280.50610536.00-0.299-0.1620.011
put45.000.300.450.400.48412111.00-0.402-0.1730.013
put45.500.500.650.570.4563.001.00-0.520-0.1700.013
put46.000.800.901.630.45658.000.00-0.643-0.1530.012
put46.501.151.252.030.4458.000.00-0.753-0.1280.010
put47.001.152.001.520.75268.000.00-0.791-0.1420.009
put47.501.652.902.201.2293.000.00-0.804-0.1670.009
put48.002.153.702.601.6083.000.00-0.820-0.1830.009
put48.502.554.003.181.5555.000.00-0.861-0.1550.007
put49.003.105.003.672.1044.000.00-0.902-0.1160.006
put49.503.505.604.962.3052.001.00-0.930-0.0880.004
put50.004.106.105.382.4190.001.00-0.952-0.0630.003
put51.005.007.107.562.6360.000.00-0.958-0.0660.003
put52.006.007.908.302.6581.001.00-0.962-0.0690.003
put53.007.009.009.222.9430.001.00-0.966-0.0710.002
put54.008.1010.0010.533.1271.000.00-0.968-0.0730.002
put55.009.1011.1011.463.4001.000.00-0.970-0.0750.002
put56.0010.0012.100.003.5710.000.00-0.972-0.0770.002
put60.0014.1015.500.003.5220.000.00-0.977-0.0820.002
put65.0019.0021.100.004.8800.000.00-0.981-0.0870.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-06SCHEDULE 13G/ASEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-11-0210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-078-KCurrent report2026-10-01SEC
2026-09-238-KCurrent report2026-09-21SEC
2026-09-088-KCurrent report2026-09-07SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-268-KCurrent report2026-08-26SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-06SCHEDULE 13G/ASEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-278-KCurrent report2026-07-21SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-2411-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-21SDSpecialized Disclosure ReportSEC
2026-05-188-KCurrent report2026-05-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-089.26M500
2026-07227.40K100
2026-060000
2026-05554.00K400
2026-040000
2026-030000
2026-020015.04M1
2026-010000
2025-12001.76M1
2025-11006.24M2

Institutional holders

Manager% owned
BlackRock, Inc.8.72%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP4.72%
PRIMECAP MANAGEMENT CO/CA/3.40%
FMR LLC2.77%
GEODE CAPITAL MANAGEMENT, LLC2.38%
VANGUARD PORTFOLIO MANAGEMENT LLC2.00%
D. E. Shaw & Co., Inc.1.71%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.67%
JPMORGAN CHASE & CO1.61%

Funds

Fund% owned
The Osterweis Strategic Income Fund3.36%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
PIMCO Long Duration Credit Bond Portfolio2.42%
Thornburg Capital Management Fund2.31%
VANGUARD PRIMECAP FUND2.07%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND1.76%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.33%
SPDR S&P 500 ETF TRUST1.21%

OakChart. BSX. Cached 15 minutes.